Marksans Pharma Limited has informed the Exchange regarding a press release dated January 23, 2023, titled "Marksans Pharma Limited announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution.".
Marksans Pharma Limited has informed the Exchange regarding a press release dated January 23, 2023, titled "Marksans Pharma Limited announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution.".